It has been reported that a polymorphism in PPARδ modifies the protective effects of nonsteroidal anti-inflammatory drugs on colorectal adenomas (Siezen et al, 2006), but other investigators have not reached the same conclusions in the context of CRC (McGreavey et al, 2005). The gene discussed is PPARD; the disease is colorectal carcinoma.